Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.

@article{Spanakis2006ModestBS,
  title={Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.},
  author={Elias K Spanakis and Prodromos I Sidiropoulos and John Papadakis and Emmanuel S. Ganotakis and George Katsikas and Stylianos A Karvounaris and Argyro G Bizaki and Heraklis D. Kritikos and Dimitrios T. Boumpas},
  journal={The Journal of rheumatology},
  year={2006},
  volume={33 12},
  pages={2440-6}
}
OBJECTIVE Tumor necrosis factor-a (TNF-a) is a key cytokine in the pathogenesis of chronic inflammatory arthritides, has proatherogenic effects, and may be positively correlated with impairment of the action of insulin. Patients with chronic inflammatory arthritides have an increased risk for cardiovascular diseases. We assessed whether anti-TNF-a treatment modifies the unfavorable lipid profile induced by chronic inflammatory arthritides. METHODS Sixty patients (24 with rheumatoid arthritis… CONTINUE READING